Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
0.8393
+0.0143 (1.73%)
At close: Dec 5, 2025, 4:00 PM EST
0.8106
-0.0287 (-3.42%)
After-hours: Dec 5, 2025, 7:48 PM EST
Propanc Biopharma Market Cap
Propanc Biopharma has a market cap or net worth of $11.22 million as of December 5, 2025.
Market Cap
11.22M
Enterprise Value
11.31M
1-Year Change
n/a
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since August 15, 2025, Propanc Biopharma's market cap has decreased from $36.20M to $11.22M, a decrease of -69.01%. That is a compound annual growth rate of -97.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 11.20M | 1.82% |
| Dec 4, 2025 | 11.00M | -0.90% |
| Dec 3, 2025 | 11.10M | 3.74% |
| Dec 2, 2025 | 10.70M | -15.08% |
| Dec 1, 2025 | 12.60M | 5.88% |
| Nov 28, 2025 | 11.90M | 10.19% |
| Nov 26, 2025 | 10.80M | -1.82% |
| Nov 25, 2025 | 11.00M | 1.85% |
| Nov 24, 2025 | 10.80M | - |
| Nov 21, 2025 | 10.80M | -2.70% |
| Nov 20, 2025 | 11.10M | -3.48% |
| Nov 19, 2025 | 11.50M | 4.55% |
| Nov 18, 2025 | 11.00M | 8.91% |
| Nov 17, 2025 | 10.10M | -2.88% |
| Nov 14, 2025 | 10.40M | 4.00% |
| Nov 13, 2025 | 10.00M | -6.54% |
| Nov 12, 2025 | 10.70M | -0.93% |
| Nov 11, 2025 | 10.80M | -18.18% |
| Nov 10, 2025 | 13.20M | - |
| Nov 7, 2025 | 13.20M | -7.69% |
| Nov 6, 2025 | 14.30M | -5.30% |
| Nov 5, 2025 | 15.10M | 11.03% |
| Nov 4, 2025 | 13.60M | -6.21% |
| Nov 3, 2025 | 14.50M | -8.81% |
| Oct 31, 2025 | 15.90M | - |
View and export this data all the way back to 2025. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 902.55B |
| Johnson & Johnson | 487.57B |
| AbbVie | 400.28B |
| UnitedHealth Group | 299.66B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 248.67B |
| Abbott Laboratories | 218.00B |